Showing 42,701 - 42,720 results of 66,758 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (mean decrease)) ))', query time: 1.50s Refine Results
  1. 42701
  2. 42702

    DataSheet_1_Deciphering the Prognostic and Predictive Value of Urinary CXCL10 in Kidney Recipients With BK Virus Reactivation.pdf by Claire Tinel (9754226)

    Published 2020
    “…In viremic patients, uCXCL10 at biopsy was associated with graft functional decline [HR = 1.65, 95% CI (1.08–2.51), P = 0.02], irrespective of baseline eGFR, blood viral load, or BKVN diagnosis. uCXL10/cr (threshold: 12.86 ng/mmol) discriminated patients with a low risk of graft function decline from high-risk patients (P = 0.01). …”
  3. 42703
  4. 42704
  5. 42705

    Interaction between the N-terminus of both caspase 8 and SPARC are required to reduce cell viability and enhance apoptosis. by Mahbuba Rahman (198499)

    Published 2011
    “…<p><b>A–B</b>) Cell viability further decreased in MIP/SP and MIP/SP-N after transfection with wild-type caspase 8 and 5-FU treatment, relative to empty vector (EV, control): MIP/SP: 77.2±3.8 (EV) vs. 59.1±1.5% (caspase 8) (p<0.005); MIP/SP-N: 68.8±4.8 (EV) vs. 50.6±3.6% (caspase 8) (p = 0.04). …”
  6. 42706
  7. 42707

    Transient expression of CSE-induced <i>Cox-2</i> mRNA is due to AhR-dependent mRNA destabilization. by Michela Zago (463762)

    Published 2013
    “…<i>Cox-2</i> mRNA expression remained relatively unchanged in <i>AhR<sup>−/−</sup></i> lung cells whereas there was a rapid and significant decline in <i>Cox-2</i> mRNA in <i>AhR<sup>+/+</sup></i> cells after exposure to ActD (**p<0.01 compared to CSE-only exposed control cells; <sup>$$</sup>p<0.01 compared to <i>AhR<sup>−/−</sup></i> lung at the respective time-point after ActD treatment). …”
  8. 42708
  9. 42709

    Data_Sheet_1_Genetic and Metabolite Variability in One-Carbon Metabolism Applied to an Insulin Resistance Model in Patients With Schizophrenia Receiving Atypical Antipsychotics.doc... by Kristen M. Ward (10869249)

    Published 2021
    “…All factors included in this final model were considered as having a possible effect on predicting log(HOMA-IR) as measured with a p-value < 0.1.…”
  10. 42710

    Image_1_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.pdf by Jun-Bing Chen (14296940)

    Published 2022
    “…Analogously, there was a significant decrease for dichotomous TTS (within vs over 5 weeks) in OS (P = .03) and progression free survival (PFS) (P = .01) but not for dichotomous TAC (within vs over 6 weeks) in OS and PFS (P = .40). …”
  11. 42711
  12. 42712

    Image_2_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.pdf by Jun-Bing Chen (14296940)

    Published 2022
    “…Analogously, there was a significant decrease for dichotomous TTS (within vs over 5 weeks) in OS (P = .03) and progression free survival (PFS) (P = .01) but not for dichotomous TAC (within vs over 6 weeks) in OS and PFS (P = .40). …”
  13. 42713

    Table_2_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.docx by Jun-Bing Chen (14296940)

    Published 2022
    “…Analogously, there was a significant decrease for dichotomous TTS (within vs over 5 weeks) in OS (P = .03) and progression free survival (PFS) (P = .01) but not for dichotomous TAC (within vs over 6 weeks) in OS and PFS (P = .40). …”
  14. 42714

    Table_3_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.docx by Jun-Bing Chen (14296940)

    Published 2022
    “…Analogously, there was a significant decrease for dichotomous TTS (within vs over 5 weeks) in OS (P = .03) and progression free survival (PFS) (P = .01) but not for dichotomous TAC (within vs over 6 weeks) in OS and PFS (P = .40). …”
  15. 42715
  16. 42716
  17. 42717

    Table_1_The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.docx by Jun-Bing Chen (14296940)

    Published 2022
    “…Analogously, there was a significant decrease for dichotomous TTS (within vs over 5 weeks) in OS (P = .03) and progression free survival (PFS) (P = .01) but not for dichotomous TAC (within vs over 6 weeks) in OS and PFS (P = .40). …”
  18. 42718
  19. 42719

    NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease by Joshua J. Field (176969)

    Published 2017
    “…All subjects in the higher dose cohorts (0.1 mg/kg, 0.3 mg/kg, and 1 mg/kg) demonstrated decreased iNKT cells below the lower limit of quantification within 6 hours after infusion, the earliest time point at which they were measured. …”
  20. 42720

    Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease by Dejan Micic (386890)

    Published 2017
    “…Increasing patient age (> 65: OR: 0.45; 95% CI 0.39–0.53) was associated with a decreased risk of readmission, while a diagnosis of Crohn’s disease (OR: 1.09; 95% CI 1.00–1.18) and male sex (OR: 1.16; 95% CI 1.07–1.25) were associated with an increased risk of readmission. …”